Third Rock Ventures II, L.P., 10% Owner at Global Blood Therapeutics, Inc. (GBT), sold 1,000,000 shares at $19.36 ($19.4M) on 2016-11-14, disclosed to the SEC on 2016-11-16.
Open-market sale of $19.4M GBT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |